Entry |
|
Symbol |
PIK3R1
|
Name |
(RefSeq) phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1
|
KO |
K02649 | phosphoinositide-3-kinase regulatory subunit alpha/beta/delta |
|
Organism |
lav Loxodonta africana (African savanna elephant)
|
Pathway |
lav01521 | EGFR tyrosine kinase inhibitor resistance |
lav04070 | Phosphatidylinositol signaling system |
lav04072 | Phospholipase D signaling pathway |
lav04213 | Longevity regulating pathway - multiple species |
lav04550 | Signaling pathways regulating pluripotency of stem cells |
lav04613 | Neutrophil extracellular trap formation |
lav04620 | Toll-like receptor signaling pathway |
lav04625 | C-type lectin receptor signaling pathway |
lav04650 | Natural killer cell mediated cytotoxicity |
lav04660 | T cell receptor signaling pathway |
lav04662 | B cell receptor signaling pathway |
lav04664 | Fc epsilon RI signaling pathway |
lav04666 | Fc gamma R-mediated phagocytosis |
lav04670 | Leukocyte transendothelial migration |
lav04750 | Inflammatory mediator regulation of TRP channels |
lav04810 | Regulation of actin cytoskeleton |
lav04914 | Progesterone-mediated oocyte maturation |
lav04919 | Thyroid hormone signaling pathway |
lav04923 | Regulation of lipolysis in adipocytes |
lav04932 | Non-alcoholic fatty liver disease |
lav04933 | AGE-RAGE signaling pathway in diabetic complications |
lav04935 | Growth hormone synthesis, secretion and action |
lav04960 | Aldosterone-regulated sodium reabsorption |
lav04973 | Carbohydrate digestion and absorption |
lav05100 | Bacterial invasion of epithelial cells |
lav05163 | Human cytomegalovirus infection |
lav05166 | Human T-cell leukemia virus 1 infection |
lav05167 | Kaposi sarcoma-associated herpesvirus infection |
lav05168 | Herpes simplex virus 1 infection |
lav05170 | Human immunodeficiency virus 1 infection |
lav05207 | Chemical carcinogenesis - receptor activation |
lav05208 | Chemical carcinogenesis - reactive oxygen species |
lav05230 | Central carbon metabolism in cancer |
lav05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
lav05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:lav00001]
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
100653731 (PIK3R1)
04014 Ras signaling pathway
100653731 (PIK3R1)
04015 Rap1 signaling pathway
100653731 (PIK3R1)
04370 VEGF signaling pathway
100653731 (PIK3R1)
04630 JAK-STAT signaling pathway
100653731 (PIK3R1)
04668 TNF signaling pathway
100653731 (PIK3R1)
04066 HIF-1 signaling pathway
100653731 (PIK3R1)
04068 FoxO signaling pathway
100653731 (PIK3R1)
04070 Phosphatidylinositol signaling system
100653731 (PIK3R1)
04072 Phospholipase D signaling pathway
100653731 (PIK3R1)
04071 Sphingolipid signaling pathway
100653731 (PIK3R1)
04024 cAMP signaling pathway
100653731 (PIK3R1)
04151 PI3K-Akt signaling pathway
100653731 (PIK3R1)
04152 AMPK signaling pathway
100653731 (PIK3R1)
04150 mTOR signaling pathway
100653731 (PIK3R1)
09133 Signaling molecules and interaction
04081 Hormone signaling
100653731 (PIK3R1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100653731 (PIK3R1)
09143 Cell growth and death
04210 Apoptosis
100653731 (PIK3R1)
04218 Cellular senescence
100653731 (PIK3R1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100653731 (PIK3R1)
04550 Signaling pathways regulating pluripotency of stem cells
100653731 (PIK3R1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100653731 (PIK3R1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100653731 (PIK3R1)
04613 Neutrophil extracellular trap formation
100653731 (PIK3R1)
04620 Toll-like receptor signaling pathway
100653731 (PIK3R1)
04625 C-type lectin receptor signaling pathway
100653731 (PIK3R1)
04650 Natural killer cell mediated cytotoxicity
100653731 (PIK3R1)
04660 T cell receptor signaling pathway
100653731 (PIK3R1)
04662 B cell receptor signaling pathway
100653731 (PIK3R1)
04664 Fc epsilon RI signaling pathway
100653731 (PIK3R1)
04666 Fc gamma R-mediated phagocytosis
100653731 (PIK3R1)
04670 Leukocyte transendothelial migration
100653731 (PIK3R1)
04062 Chemokine signaling pathway
100653731 (PIK3R1)
09152 Endocrine system
04910 Insulin signaling pathway
100653731 (PIK3R1)
04923 Regulation of lipolysis in adipocytes
100653731 (PIK3R1)
04929 GnRH secretion
100653731 (PIK3R1)
04915 Estrogen signaling pathway
100653731 (PIK3R1)
04914 Progesterone-mediated oocyte maturation
100653731 (PIK3R1)
04917 Prolactin signaling pathway
100653731 (PIK3R1)
04926 Relaxin signaling pathway
100653731 (PIK3R1)
04935 Growth hormone synthesis, secretion and action
100653731 (PIK3R1)
04919 Thyroid hormone signaling pathway
100653731 (PIK3R1)
09154 Digestive system
04973 Carbohydrate digestion and absorption
100653731 (PIK3R1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100653731 (PIK3R1)
09156 Nervous system
04725 Cholinergic synapse
100653731 (PIK3R1)
04722 Neurotrophin signaling pathway
100653731 (PIK3R1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100653731 (PIK3R1)
09158 Development and regeneration
04360 Axon guidance
100653731 (PIK3R1)
04380 Osteoclast differentiation
100653731 (PIK3R1)
09149 Aging
04211 Longevity regulating pathway
100653731 (PIK3R1)
04213 Longevity regulating pathway - multiple species
100653731 (PIK3R1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100653731 (PIK3R1)
05206 MicroRNAs in cancer
100653731 (PIK3R1)
05205 Proteoglycans in cancer
100653731 (PIK3R1)
05207 Chemical carcinogenesis - receptor activation
100653731 (PIK3R1)
05208 Chemical carcinogenesis - reactive oxygen species
100653731 (PIK3R1)
05203 Viral carcinogenesis
100653731 (PIK3R1)
05230 Central carbon metabolism in cancer
100653731 (PIK3R1)
05231 Choline metabolism in cancer
100653731 (PIK3R1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100653731 (PIK3R1)
09162 Cancer: specific types
05210 Colorectal cancer
100653731 (PIK3R1)
05212 Pancreatic cancer
100653731 (PIK3R1)
05225 Hepatocellular carcinoma
100653731 (PIK3R1)
05226 Gastric cancer
100653731 (PIK3R1)
05214 Glioma
100653731 (PIK3R1)
05221 Acute myeloid leukemia
100653731 (PIK3R1)
05220 Chronic myeloid leukemia
100653731 (PIK3R1)
05218 Melanoma
100653731 (PIK3R1)
05211 Renal cell carcinoma
100653731 (PIK3R1)
05215 Prostate cancer
100653731 (PIK3R1)
05213 Endometrial cancer
100653731 (PIK3R1)
05224 Breast cancer
100653731 (PIK3R1)
05222 Small cell lung cancer
100653731 (PIK3R1)
05223 Non-small cell lung cancer
100653731 (PIK3R1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100653731 (PIK3R1)
05170 Human immunodeficiency virus 1 infection
100653731 (PIK3R1)
05161 Hepatitis B
100653731 (PIK3R1)
05160 Hepatitis C
100653731 (PIK3R1)
05171 Coronavirus disease - COVID-19
100653731 (PIK3R1)
05164 Influenza A
100653731 (PIK3R1)
05162 Measles
100653731 (PIK3R1)
05168 Herpes simplex virus 1 infection
100653731 (PIK3R1)
05163 Human cytomegalovirus infection
100653731 (PIK3R1)
05167 Kaposi sarcoma-associated herpesvirus infection
100653731 (PIK3R1)
05169 Epstein-Barr virus infection
100653731 (PIK3R1)
05165 Human papillomavirus infection
100653731 (PIK3R1)
09171 Infectious disease: bacterial
05135 Yersinia infection
100653731 (PIK3R1)
05100 Bacterial invasion of epithelial cells
100653731 (PIK3R1)
09174 Infectious disease: parasitic
05146 Amoebiasis
100653731 (PIK3R1)
05142 Chagas disease
100653731 (PIK3R1)
09164 Neurodegenerative disease
05010 Alzheimer disease
100653731 (PIK3R1)
05017 Spinocerebellar ataxia
100653731 (PIK3R1)
05020 Prion disease
100653731 (PIK3R1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100653731 (PIK3R1)
05418 Fluid shear stress and atherosclerosis
100653731 (PIK3R1)
05415 Diabetic cardiomyopathy
100653731 (PIK3R1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100653731 (PIK3R1)
04932 Non-alcoholic fatty liver disease
100653731 (PIK3R1)
04931 Insulin resistance
100653731 (PIK3R1)
04933 AGE-RAGE signaling pathway in diabetic complications
100653731 (PIK3R1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100653731 (PIK3R1)
01524 Platinum drug resistance
100653731 (PIK3R1)
01522 Endocrine resistance
100653731 (PIK3R1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:lav04131]
100653731 (PIK3R1)
Membrane trafficking [BR:lav04131]
Endocytosis
Rab GTPases and associated proteins
Rab associated proteins
100653731 (PIK3R1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
724 aa
MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYN
ETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADSEQQALTLLDLAE
QFAPPDIAPPLLVKLVEAIEKKGLECSTLYRTQSSSSPAELRQLLDCDVTSVDWEMIDVH
VLADAFKRYLLDLPNPVIPGAVYSEMMSLAQEVQSSEEHIQLLKKLIRSPNIPHQYWLTL
QYLLKHFFKLSQTASKNLLNARALSEIFSPMLFRFPANSSDNTEHLIKVVEILISTEWNE
RQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDA
STKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNSVVELINHYRNESLAQYNPKL
DVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEDYTRTSQEIQMK
RTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYEKLKSRISEIVD
SRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLLWLTQKGVRQKKLNEWLGN
ENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACS
VVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYA
QQRR |
NT seq |
2175 nt +upstreamnt +downstreamnt
atgagtgctgaggggtaccagtacagagcgctgtatgattataaaaaggaacgagaagaa
gacattgacctgcatttgggtgacatattgactgtgaataaagggtctttggtagctctt
ggattcagtgatggacaggaagccaggcctgaagaaattggctggttgaatggctataat
gaaaccacgggggaaaggggagactttccgggaacatatgtagaatatattggaaggaaa
aaaatctcacctcccacaccaaagccccggccacctcgaccccttcctgttgcaccaggt
tcttcaaaaactgaagcagacagtgagcaacaagctttgactcttctggatcttgcagag
cagtttgcccctcctgacattgctccccctcttcttgtcaagctagtggaagccattgaa
aagaaaggtctggaatgttcaactctatacagaacacagagctctagcagcccagcagaa
ttacgacagcttcttgattgtgatgtcacctccgtggactgggaaatgatcgatgtgcac
gttttagcagatgctttcaaacgctatcttctggacttgccaaatcctgtcattccagga
gccgtttacagtgaaatgatgtctttagcccaagaagtacagagctccgaagaacatatc
cagctgttgaagaagctcattaggtcaccgaacatacctcatcagtattggcttacactt
cagtatttgctaaaacatttcttcaagctctctcaaacggccagcaaaaatctcttgaat
gcaagagcactctctgaaattttcagccctatgcttttcagattcccagcaaacagctct
gataatactgaacacctcataaaagttgtagaaattttaatctcaacggaatggaatgaa
cggcagcctgcaccagcactgccccctaaaccacccaagcccactactgtagccaacaac
ggtatgaataacaatatgtccttacaagatgctgaatggtactggggagatatctcgagg
gaagaagtgaatgaaaaacttcgagatacagcagatgggacgtttttggtacgagatgcc
tctactaaaatgcatggtgattatacgcttacactaaggaaaggaggaaataacaaatta
atcaaaatatttcaccgagatgggaaatatggcttctctgacccattaactttcaactct
gtggttgaactaataaaccactaccggaatgaatctctagctcagtataatcccaagctg
gatgtgaaattgctttatccagtatccaaataccaacaggatcaagtggtcaaagaagat
aatattgaagctgtagggaaaaaattacatgaatataacactcaattccaagaaaaaagt
cgggagtatgatagattatatgaagattatacccgtacttcccaggaaatccaaatgaaa
agaacagctattgaagcatttaatgaaaccataaaaatatttgaagaacagtgccaaacc
caggagcggtacagcaaagaatacatagaaaagtttaaacgtgaaggcaatgagaaagaa
atacaaaggattatgcataattatgaaaagttaaagtcgcgcatcagtgagattgtcgac
agtcgaagaagattggaggaagacttgaagaagcaggcagctgagtatcgagagattgac
aaacgtatgaatagcatcaaaccagacctcatccagctgagaaagacaagagaccaatac
ttgctgtggttgactcaaaaaggtgttcggcagaagaagttgaacgagtggctgggcaat
gaaaacactgaagatcaatattcactggtggaagatgacgaggatttaccccaccacgat
gagaagacctggaatgtgggaagcagcaaccggaacaaagctgagaacctattgcgaggg
aagcgggatggcactttccttgtccgagagagcagtaaacagggctgttacgcctgctct
gtagtggtggatggcgaggtaaagcattgtgtcataaacaagacggcaactgggtatggc
tttgcagagccctataacttgtacagctccctgaaagaactggtgctacattaccaacac
acgtccctcgtgcagcacaacgactccctcaacgtcacactagcctacccagtatatgca
cagcagaggcgatga |